{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:32:56Z","timestamp":1793161976142,"version":"4.5.0"},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circ: Heart Failure"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1161\/circheartfailure.108.839761","type":"journal-article","created":{"date-parts":[[2009,3,17]],"date-time":"2009-03-17T21:35:08Z","timestamp":1237325708000},"page":"138-144","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":231,"title":["Small Animal Models of Heart Failure"],"prefix":"10.1161","volume":"2","author":[{"given":"Richard D.","family":"Patten","sequence":"first","affiliation":[{"name":"From the Molecular Cardiology Research Institute, Tufts Medical Center, Boston, Mass."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica R.","family":"Hall-Porter","sequence":"additional","affiliation":[{"name":"From the Molecular Cardiology Research Institute, Tufts Medical Center, Boston, Mass."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","first-page":"257","volume":"22","year":"1963","unstructured":"Zbinden G, Bagdon RE. Isoproterenol-induced heart necrosis, an experimental model for the study of angina pectoris and myocardial infarct. Rev Can Biol. 1963; 22: 257\u2013263.","journal-title":"Rev Can Biol"},{"key":"e_1_3_2_2_2","first-page":"203","volume":"17","year":"1976","unstructured":"Adler N, Camin LL, Shulkin P. Rat model for acute myocardial infarction: application to technetium-labeled glucoheptonate, tetracycline, and polyphosphate. J Nucl Med. 1976; 17: 203\u2013207.","journal-title":"J Nucl Med"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.44.4.428047"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.49.3.7261261"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.57.1.3891127"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.72.2.3891136"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198807143190204"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199209033271001"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.89.1.8281697"},{"key":"e_1_3_2_10_2","first-page":"772","volume":"20","year":"1992","unstructured":"Smits JFM, van Krimpen C, Schoemaker RG, Cleutjens JPM, Daemen MJAP. Angiotensin II receptor blockade after myocardial infarction in rats: effects on hemodynamics, myocardial DNA synthesis, and interstitial collagen content. J Cardiovasc Pharmacol. 1992; 20: 772\u2013778.","journal-title":"J Cardiovasc Pharmacol"},{"key":"e_1_3_2_11_2","first-page":"625","volume":"47","year":"1997","unstructured":"Hayashi N, Fujimura Y, Yamamoto S, Kometani M, Nakao K. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist IV communication: improvement of heart failure of rats with myocardial infarction by valasartan. Arzneimittelforschung. 1997; 47: 625\u2013629.","journal-title":"Arzneimittelforschung"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/384353a0"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2004.05.006"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1997.83.4.1209"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012212"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.106.671701"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.61.1.3608112"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.90.3.8087951"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114924"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.91.10.2642"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.2.793"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.104.12.1424"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2008.02.005"},{"key":"e_1_3_2_24_2","first-page":"H2471","volume":"267","year":"1994","unstructured":"Inoko M, Kihara Y, Morii I, Fujiwara H, Sasayama S. Transition from compensatory hypertrophy to dilated, failing left ventricles in Dahl salt-sensitive rats. Am J Physiol. 1994; 267: H2471\u201382.","journal-title":"Am J Physiol"},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","unstructured":"McCune S Park S Radin M Jurin R. HHF\/Mcc-facp rat model: a genetic model of congestive heart failure. In: Singal P Dixon I Beamish R Dhalla R eds. Mechanisms of Heart Failure. Dordrecht The Netherlands: Kluwer Academic Publishers; 1995: 91\u2013106.","DOI":"10.1007\/978-1-4615-2003-0_8"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00305.2002"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ultrasmedbio.2007.01.019"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.1998.274.4.H1416"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2008.138"},{"key":"e_1_3_2_30_2","first-page":"308","volume":"20","year":"1978","unstructured":"Zolotareva AG, Kogan ME. Production of experimental occlusive myocardial infarction in mice. Cor Vasa. 1978; 20: 308\u2013314.","journal-title":"Cor Vasa"},{"key":"e_1_3_2_31_2","first-page":"H2147","volume":"269","year":"1995","unstructured":"Michael LH, Entman ML, Hartley CJ, Youker KA, Zhu J, Hall SR, Hawkins HK, Berens K, Ballantyne CM. Myocardial ischemia and reperfusion: a murine model. Am J Physiol. 1995; 269: H2147\u2013H2154.","journal-title":"Am J Physiol"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.1998.274.5.H1812"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119656"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2004.11.002"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.res.0000069686.31472.c5"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1215"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.18.8277"},{"key":"e_1_3_2_38_2","first-page":"H2468","volume":"266","year":"1994","unstructured":"Rockman HA, Wachhorst SP, Mao L, Ross J. ANG II receptor blockade prevents ventricular hypertrophy and ANF gene expression with pressure overload in mice. Am J Physiol. 1994; 266: H2468\u2013H2475.","journal-title":"Am J Physiol"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2007.10.024"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00816.2006"},{"key":"e_1_3_2_41_2","doi-asserted-by":"crossref","first-page":"L429","DOI":"10.1152\/ajplung.2000.279.3.L429","volume":"279","year":"2000","unstructured":"Dempsey EC, Newton AC, Mochly-Rosen D, Fields AP, Reyland ME, Insel PA, Messing RO. Protein kinase C isozymes and the regulation of diverse cell responses. Am J Physiol Lung Cell Mol Physiol. 2000; 279: L429\u2013L438.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.res.0000105087.79373.17"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1000"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.res.0000234780.06115.2c"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1175"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.106.626226"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1253\/circj.66.219"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81878-4"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.81.4.627"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.101.21.2518"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.23.12746"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000124490.27666.b2"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1038\/74914"}],"container-title":["Circulation: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/CIRCHEARTFAILURE.108.839761","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T01:28:58Z","timestamp":1715563738000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/CIRCHEARTFAILURE.108.839761"}},"subtitle":["Development of Novel Therapies, Past and Present"],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["10.1161\/CIRCHEARTFAILURE.108.839761"],"URL":"https:\/\/doi.org\/10.1161\/circheartfailure.108.839761","relation":{},"ISSN":["1941-3289","1941-3297"],"issn-type":[{"value":"1941-3289","type":"print"},{"value":"1941-3297","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3]]},"assertion":[{"value":"2009-03-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}